BAYER C1000 Pill — WHITE OVAL, 23mm — Ciprofloxacin
| Imprint | BAYER / C1000 |
|---|---|
| Colour | WHITE |
| Shape | OVAL |
| Size | 23 |
| Strength | CIPROFLOXACIN 452.2 mg;CIPROFLOXACIN HYDROCHLORIDE 574.9 1 |
| Dosage form | Tablet, Film Coated, Extended Release |
| Manufacturer | Bayer HealthCare Pharmaceuticals Inc. |
| NDC | 50419-789 |
| Schedule | — |
| Availability | — |
| Ingredients | CIPROFLOXACIN[CIPROFLOXACIN];CIPROFLOXACIN HYDROCHLORIDE[CIPROFLOXACIN] |
What does this imprint mean?
The imprint "BAYER C1000" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Ciprofloxacin
Uses and warnings
BOXED WARNING: BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Risk of tendon rupture (especially Achilles tendon), particularly in patients over 60, on corticosteroids, or with organ transplants - Peripheral neuropathy with potentially irreversible symptoms - CNS effects: psychiatric reactions, seizures, hallucinations, depression with suicidal ideation - Serious hypersensitivity/anaphylactic reactions possible - Hepatotoxicity including fatal hepatic failure reported - QT interval prolongation and torsade de pointes risk - Aortic aneurysm and dissection risk in elderly patients - C. difficile-associated diarrhea possible | BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Ris
Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18+ years) and select pediatric patients for treating infections including: skin/skin structure infections, bone and joint infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, uncomplicated gonorrhea, inhalational anthrax post-exposure, plague, chronic bacterial prostatitis, lower respiratory tract infections, urinary tract infections, and acute sinusitis. The label emphasizes reserving use for patients with no alternative treatment options for certain conditions like acute uncomplicated cystitis and acute bronchitis exacerbations due to serious adverse risks.
How to identify this pill
- • Check the imprint matches exactly: "BAYER C1000".
- • Confirm the colour (WHITE) and shape (OVAL).
- • Compare the size (23) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
P469
WHITE OVAL · Potassium Chloride
PD 157
WHITE OVAL · Atorvastatin
L544
WHITE OVAL · Acetaminophen
U 227
WHITE OVAL · Metronidazole
APO 084
WHITE OVAL · Paroxetine
O E
WHITE OVAL · Gabapentin
SZ441
WHITE OVAL · Metformin
M136
WHITE OVAL · Folic Acid
3594 V
WHITE OVAL · Hydrocodone
PD 156
WHITE OVAL · Atorvastatin
2087 V
WHITE OVAL · Alprazolam
NT 151
WHITE OVAL · Gabapentin
Other pills of Ciprofloxacin
CR 250
WHITE ROUND · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
P 500
WHITE BULLET · Ciprofloxacin
WW929
WHITE CAPSULE · Ciprofloxacin
R 126
WHITE OVAL · Ciprofloxacin
C 94
WHITE CAPSULE · Ciprofloxacin
CR 250
WHITE ROUND · Ciprofloxacin
C 95
WHITE ROUND · Ciprofloxacin
TEVA 5312
WHITE OVAL · Ciprofloxacin
T92
WHITE ROUND · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 6a45ebbd-49c4-4177-8ee3-ad4e02b780da.xml